Abstract
Background
A significant shift toward high folate concentrations has been taking place following the mandatory folate fortification. Yet the relationship between folate and health outcomes beyond neural tube defects remains understudied. We longitudinally examined relationships between serum folate and risk of cardiovascular death.
Methods
We analyzed data of 3116 adults aged ≥19 who participated in the Third National Health and Nutrition Examination Survey, 1991–1994 and were diagnosed with hypertension. Vital status was followed through December 31, 2010. Cox regression was used to estimate hazard ratios (HRs) of cardiovascular deaths for individuals with serum folate in the first quartile and fourth quartile compared with the patients with interquartile folate.
Results
After 33627 person years (p*ys) of follow-up, 1298 deaths were recorded with 638 cardiovascular disease (CVD) deaths (109 strokes and 529 heart diseases). A U-shaped association appeared after multivariable adjustment for heart disease, acute myocardial infarction, and overall CVD deaths. The mortality rate for heart disease in patients with low, moderate, and high folate were 12.18/1000 p*ys, 14.12/1000 p*ys, and 23.80/1000 p*ys, respectively, and the corresponding adjusted HRs were 1.79 (95% confidence interval, CI = 1.63–1.98), 1.00 (reference), and 1.31 (1.17–1.46). The HRs of acute myocardial infarction were 2.28 (1.80–2.88), 1.00 (reference), and 1.77 (1.42–2.20) for hypertensive patients with serum folate in low quartile, interquartile, and high quartile, respectively.
Conclusions
Among hypertensive adults, both low and high folate were associated with an elevated risk of dying from cardiovascular diseases compared with adults with moderate serum folate concentration.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pfeiffer CM, Hughes JP, Lacher DA, Bailey RL, Berry RJ, Zhang M, et al. Estimation of trends in serum and RBC folate in the U.S. population from pre- to postfortification using assay-adjusted data from the NHANES 1988-2010. J Nutr. 2012;142:886–93. https://doi.org/10.3945/jn.111.156919
Schwartz SM, Siscovick DS, Malinow MR, Rosendaal FR, Beverly RK, Hess DL, et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation. 1997;96:412–7.
Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PW, Belanger AJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–91. https://doi.org/10.1056/NEJM199502023320502
Loria CM, Ingram DD, Feldman JJ, Wright JD, Madans JH. Serum folate and cardiovascular disease mortality among US men and women. Arch Intern Med. 2000;160:3258–62.
Morrison HI, Schaubel D, Desmeules M, Wigle DT. Serum folate and risk of fatal coronary heart disease. JAMA. 1996;275:1893–6.
Folsom AR, Nieto FJ, McGovern PG, Tsai MY, Malinow MR, Eckfeldt JH, et al. Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 1998;98:204–10.
Voutilainen S, Rissanen TH, Virtanen J, Lakka TA, Salonen JT. Kuopio Ischemic Heart Disease Risk Factor S. Low dietary folate intake is associated with an excess incidence of acute coronary events: the Kuopio Ischemic Heart Disease Risk Factor Study. Circulation. 2001;103:2674–80.
Huang YC, Lee MS, Wahlqvist ML. Prediction of all-cause mortality by B group vitamin status in the elderly. Clin Nutr. 2012;31:191–8. https://doi.org/10.1016/j.clnu.2011.10.010
Xun P, Liu K, Loria CM, Bujnowski D, Shikany JM, Schreiner PJ, et al. Folate intake and incidence of hypertension among American young adults: a 20-y follow-up study. Am J Clin Nutr. 2012;95:1023–30. https://doi.org/10.3945/ajcn.111.027250
Hung J, Beilby JP, Knuiman MW, Divitini M. Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia. Brit Med J. 2003;326:131.
Dangour AD, Breeze E, Clarke R, Shetty PS, Uauy R, Fletcher AE. Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J Nutr. 2008;138:1121–8.
Chasan-Taber L, Selhub J, Rosenberg IH, Malinow MR, Terry P, Tishler PV, et al. A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians. J Am Coll Nutr. 1996;15:136–43.
Roswall N, Olsen A, Christensen J, Hansen L, Dragsted LO, Overvad K, et al. Micronutrient intake in relation to all-cause mortality in a prospective Danish cohort. Food Nutr. Res. 2012;56 https://doi.org/10.3402/fnr.v56i0.5466
Bird JK, Ronnenberg AG, Choi SW, Du F, Mason JB, Liu Z. Obesity is associated with increased red blood cell folate despite lower dietary intakes and serum concentrations. J Nutr. 2015;145:79–86. https://doi.org/10.3945/jn.114.199117
MacKenzie KE, Wiltshire EJ, Gent R, Hirte C, Piotto L, Couper JJ. Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus. Pediatrics. 2006;118:242–53. https://doi.org/10.1542/peds.2005-2143
Mierzecki A, Kloda K, Bukowska H, Chelstowski K, Makarewicz-Wujec M, Kozlowska-Wojciechowska M. Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors. Med Sci Monit. 2013;19:733–9. https://doi.org/10.12659/MSM.889087
Wu CJ, Wang L, Li X, Wang CX, Ma JP, Xia XS. Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients. Zhonghua Xin Xue Guan Bing Za Zhi. 2012;40:1003–8.
Aghamohammadi V, Gargari BP, Aliasgharzadeh A. Effect of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J Am Coll Nutr. 2011;30:210–5.
Gargari BP, Aghamohammadi V, Aliasgharzadeh A. Effect of folic acid supplementation on biochemical indices in overweight and obese men with type 2 diabetes. Diabetes Res Clin Pr. 2011;94:33–8. https://doi.org/10.1016/j.diabres.2011.07.003
Zhao F, Li JP, Wang SY, Guan DM, Ge JB, Hu J, et al. The effect of baseline homocysteine level on the efficacy of enalapril maleate and folic acid tablet in lowering blood pressure and plasma homocysteine. Zhonghua Yi Xue Za Zhi. 2008;88:2957–61.
Fu J, Tang HQ, Qin XH, Mao GY, Tang GF. Efficacy of enalapril combined with folic acid in lowering blood pressure and plasma homocysteine level. Zhonghua Yi Xue Za Zhi. 2009;89:2179–83.
Huo Y, Li J, Qin X, Huang Y, Wang X, Gottesman RF, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015;313:1325–35. https://doi.org/10.1001/jama.2015.2274
Wang L, Li H, Zhou Y, Jin L, Liu J. Low-dose B vitamins supplementation ameliorates cardiovascular risk: a double-blind randomized controlled trial in healthy Chinese elderly. Eur J Nutr. 2015;54:455–64. https://doi.org/10.1007/s00394-014-0729-5
Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl J Med. 2006;354:1567–77. https://doi.org/10.1056/NEJMoa060900
Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–88. https://doi.org/10.1056/NEJMoa055227
Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565–75. https://doi.org/10.1001/jama.291.5.565
Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351–9. https://doi.org/10.1001/jama.297.21.2351
Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299:2027–36. https://doi.org/10.1001/jama.299.17.2027
Lange H, Suryapranata H, De Luca G, Borner C, Dille J, Kallmayer K, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004;350:2673–81. https://doi.org/10.1056/NEJMoa032845
Ebbing M, Bonaa KH, Nygard O, Arnesen E, Ueland PM, Nordrehaug JE, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009;302:2119–26. https://doi.org/10.1001/jama.2009.1622
Ford ES, Byers TE, Giles WH. Serum folate and chronic disease risk: findings from a cohort of United States adults. Int J Epidemiol. 1998;27:592–8.
Peng Y, Dong B, Wang Z. Serum folate concentrations and all-cause, cardiovascular disease and cancer mortality: a cohort study based on 1999-2010 National Health and Nutrition Examination Survey (NHANES). Int J Cardiol. 2016;219:136–42. https://doi.org/10.1016/j.ijcard.2016.06.024
National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey (NHANES III, 1988–94). Hyattsville, MD: US Department of Health and Human Service, Public Health Service, Center for Disease Control and Prevention, 1996
National Center for Health Statistics, Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey—About the National Health and Nutrition Examination Survey. https://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Accessed 24 Nov 2019
de Benoist B. Conclusions of a WHO technical consultation on folate and vitamin B12 deficiencies. Food Nutr Bull. 2008;29:S238–44. https://doi.org/10.1177/15648265080292S129
Lainscak M, Farkas J, Frantal S, Singer P, Bauer P, Hiesmayr M, et al. Self-rated health, nutritional intake and mortality in adult hospitalized patients. Eur J Clin Invest. 2014;44:813–24.
National Center for Health Statistics, Office of Analysis and Epidemiology. Public-use Linked Mortality File. National Center for Health Statistics, Office of Analysis and Epidemiology: Hyattsville, Maryland; 2015.
Tamai Y, Wada K, Tsuji M, Nakamura K, Sahashi Y, Watanabe K, et al. Dietary intake of vitamin B12 and folic acid is associated with lower blood pressure in Japanese preschool children. Am J Hypertens. 2011;24:1215–21. https://doi.org/10.1038/ajh.2011.133
Voutilainen S, Virtanen JK, Rissanen TH, Alfthan G, Laukkanen J, Nyyssonen K, et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2004;80:317–23. https://doi.org/10.1093/ajcn/80.2.317
Barter PJ, Rye KA. Homocysteine and cardiovascular disease: is HDL the link? Circ Res. 2006;99:565–6. https://doi.org/10.1161/01.RES.0000243583.39694.1f
Vanderwall CM, Tangney CC, Kwasny MJ, Gustashaw KA. Examination of circulating folate levels as a reflection of folate intakes among older adult supplement users and nonusers in the National Health and Nutrition Examination Survey 2003-2004. J Acad Nutr Diet. 2012;112:285–90. https://doi.org/10.1016/j.jada.2011.10.001
Oleinik NV, Krupenko NI, Reuland SN, Krupenko SA. Leucovorin-induced resistance against FDH growth suppressor effects occurs through DHFR up-regulation. Biochem Pharm. 2006;72:256–66. https://doi.org/10.1016/j.bcp.2006.04.005
Sauer J, Mason JB, Choi SW. Too much folate: a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care. 2009;12:30–6. https://doi.org/10.1097/MCO.0b013e32831cec62
Kim H, Eun Y, Song S. Serum folate and vitamin B12 levels are not associated with the incidence risk of atherosclerotic events over 12 years: the Korean Genome and Epidemiology Study. Nutr Res. 2019;63:34–41. https://doi.org/10.1016/j.nutres.2018.12.009
Weikert C, Dierkes J, Hoffmann K, Berger K, Drogan D, Klipstein-Grobusch K, et al. B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort. Stroke. 2007;38:2912–8. https://doi.org/10.1161/STROKEAHA.107.486068
Author information
Authors and Affiliations
Contributions
JZ and FL developed the original research question and oversaw the entire project. Part of the results were submitted by EI in partial fulfillment of the degree requirements for his Master of Public Health. SN and FT updated the data and rewrote the report. IC-HF supervised EI capstone project and edited the manuscript. TC helped in data analyses and manuscript rewriting.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nkemjika, S., Ifebi, E., Cowan, L.T. et al. Association between serum folate and cardiovascular deaths among adults with hypertension. Eur J Clin Nutr 74, 970–978 (2020). https://doi.org/10.1038/s41430-019-0533-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41430-019-0533-7
This article is cited by
-
Non-linear associations of serum and red blood cell folate with risk of cardiovascular and all-cause mortality in hypertensive adults
Hypertension Research (2023)
-
Folate and cardiovascular disease
Hypertension Research (2023)
-
Comparison of insulin resistance-associated parameters in US adults: a cross-sectional study
Hormones (2023)